First Header Logo Second Header Logo

Connection

Steven Feldman to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Immunosuppressive Agents.
Steven Feldman
Connection Strength
5.040
Immunosuppressive Agents
  1. Feldman SR, Lacy FA, Huang WW. The safety of treatments used in pyoderma gangrenosum. Expert Opin Drug Saf. 2018 01; 17(1):55-61.
    View in: PubMed
    Score: 0.525
  2. Davis SA, Krowchuk DP, Feldman SR. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States. South Med J. 2014 May; 107(5):292-3.
    View in: PubMed
    Score: 0.412
  3. Davis SA, Feldman SR. Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol. 2013 Apr; 149(4):490-1.
    View in: PubMed
    Score: 0.383
  4. Mudigonda T, Levender MM, O'Neill JL, West CE, Pearce DJ, Feldman SR. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010. Dermatol Surg. 2013 Mar; 39(3 Pt 1):345-64.
    View in: PubMed
    Score: 0.374
  5. Feldman SR. Let's not presuppose that patients take their medications. J Dermatolog Treat. 2012 Oct; 23(5):317.
    View in: PubMed
    Score: 0.370
  6. Uhlenhake EE, Feldman SR. Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis. Expert Opin Biol Ther. 2010 Jul; 10(7):1105-12.
    View in: PubMed
    Score: 0.316
  7. Feldman SR. Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis? J Dermatolog Treat. 2009; 20(6):317-8.
    View in: PubMed
    Score: 0.285
  8. Krejci-Manwaring J, McCarty MA, Camacho F, Manuel J, Hartle J, Fleischer A, Feldman SR. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol. 2008 Jul; 7(7):643-6.
    View in: PubMed
    Score: 0.275
  9. Conde JF, Kaur M, Fleischer AB, Tusa MG, Camacho F, Feldman SR. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008 May; 81(5):435-41.
    View in: PubMed
    Score: 0.272
  10. Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol. 2005 Jan; 141(1):43-6.
    View in: PubMed
    Score: 0.216
  11. Wilson JK, Phelps KC, Feldman SR. Use of transcutaneous nerve stimulation wristband to treat methotrexate-induced nausea. J Cutan Med Surg. 2002 Nov-Dec; 6(6):551-3.
    View in: PubMed
    Score: 0.186
  12. Yousaf A, Gayam S, Feldman S, Zinn Z, Kolodney M. Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study. J Am Acad Dermatol. 2021 01; 84(1):70-75.
    View in: PubMed
    Score: 0.160
  13. Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. J Am Acad Dermatol. 2020 Dec; 83(6):1704-1716.
    View in: PubMed
    Score: 0.160
  14. Feldman SR, Bushnell DM, Klekotka PA, Scanlon M, Martin ML, Wade SW, Yang W, Pinto L, Kircik L, Viswanathan HN. Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice. J Dermatolog Treat. 2016; 27(3):224-7.
    View in: PubMed
    Score: 0.114
  15. Farhangian ME, Feldman SR. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate. Am J Clin Dermatol. 2015 Aug; 16(4):285-294.
    View in: PubMed
    Score: 0.112
  16. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec; 71(6):1218-33.
    View in: PubMed
    Score: 0.106
  17. Kosari P, Feldman SR. Letter: Treatment-resistant pyoderma gangrenosum. Dermatol Online J. 2012 Apr 15; 18(4):8.
    View in: PubMed
    Score: 0.089
  18. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011 May; 64(5):936-49.
    View in: PubMed
    Score: 0.083
  19. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Sep; 61(3):451-85.
    View in: PubMed
    Score: 0.073
  20. Yentzer BA, Yelverton CB, Simpson GL, Simpson JF, Hwang W, Balkrishnan R, Feldman SR. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis. Dermatol Online J. 2009 Apr 15; 15(4):1.
    View in: PubMed
    Score: 0.073
  21. Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, Li S, Dooley LT, Arnold C, Gottlieb AB. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2007 Jan; 56(1):31.e1-15.
    View in: PubMed
    Score: 0.061
  22. Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Inpatient management of severe psoriasis. J Drugs Dermatol. 2005 Sep-Oct; 4(5):564-70.
    View in: PubMed
    Score: 0.057
  23. Lebwohl M, Freeman A, Chapman MS, Feldman S, Hartle J, Henning A. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol. 2005 Sep; 141(9):1154.
    View in: PubMed
    Score: 0.057
  24. Feldman SR, Nijsten T, Margolis DJ, Rolstad T. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. J Am Acad Dermatol. 2005 Jan; 52(1):140-1.
    View in: PubMed
    Score: 0.054
  25. Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004 Nov; 51(5):723-30.
    View in: PubMed
    Score: 0.053
  26. Pearce DJ, Thomas CG, Fleischer AB, Feldman SR. The cost of psoriasis therapies: considerations for therapy selection. Dermatol Nurs. 2004 Oct; 16(5):421-8, 432.
    View in: PubMed
    Score: 0.053
  27. Housman TS, Norton AB, Feldman SR, Fleischer AB, Simpson EL, Hanifin JM, Antaya RJ. Tacrolimus ointment: utilization patterns in children under age 2 years. Dermatol Online J. 2004 Jul 15; 10(1):2.
    View in: PubMed
    Score: 0.052
  28. Aung-Din D, Heath M, Wechter T, Cline A, Feldman SR, Jorizzo JL. Effectiveness of the Tacrolimus Swish-and-Spit Treatment Regimen in Patients With Geographic Tongue. JAMA Dermatol. 2018 12 01; 154(12):1481-1482.
    View in: PubMed
    Score: 0.035
  29. He A, Feldman SR, Fleischer AB. Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012. J Drugs Dermatol. 2018 Feb 01; 17(2):135-140.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.